Clinical Trial Update: InDuctIon TREatment with SubCuTaneous Infliximab for Crohn's Disease [Phase 3]

View source ↗

Summary

A Phase 3 trial is evaluating subcutaneous infliximab for Crohn's disease and is currently recruiting at Academic Medical Center - Universiteit van Amsterdam (A…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Remicade (infliximab)

Snippet

Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Conditions: Inflammatory Disease, Disease Crohn | Phase 3 | Status: RECRUITING